The population of CADM1+ CD4+ cells (D + N) was correlated with the HTLV-1 PVL values in RA participants receiving several antirheumatic therapies (R = 0.44, p = 0.0005) (Figure 3A). This evidence concerns the gene CD4 and rheumatoid arthritis.